Skip to main content
SpringerLink
Log in

Brenzkatechinamine und Myokardfunktion

  • Conference paper
Herzhypertrophie

Part of the book series: Verhandlungen der Deutschen Gesellschaft für Kreislaufforschung ((2849,volume 38))

Zusammenfassung

Die pharmakologischen Wirkungen exogen verabfolgter Brenzkatechinamine am Myokard, d. h. die Wirkungen von Noradrenalin, Adrenalin und Isoproterenol sind heute weitgehend bekannt, wenn auch der Mechanismus dieser β-sympathomimetischen Wirkungen noch nicht völlig geklärt ist. Schwieriger ist die Beurteilung der physiologischen Bedeutung der endogen freigesetzten Uberträgerstoffe des sympatho-adrenalen Systems; unter pathologischen Bedingungen sind wir bislang nahezu ausschließlich auf Hypothesen angewiesen.

Herrn Prof. Dr. Dr. E. Werle zum 70. Geburtstag am 10. 10. 1972 gewidmet.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Axelrod, J., Noradrenaline: fate and control of its biosynthesis. Science 173, 598 - 606 (1971).

    Article  PubMed  CAS  Google Scholar 

  2. Beiser, G. D., S. E. Epstein, M. Stampfer, and R. E. Goldstein, Impaired heart rate response t. o sympathetic nerve Stimulation in patients with cardiac decompensation. Circulation 38 (Suppl. 6), 40 (1968).

    Google Scholar 

  3. Bhagat, B. D., Recent advances in adrenergic mechanisms. ( Springfield/Ill. 1971 ).

    Google Scholar 

  4. Bhagat, B. and E. Friedman, Factors involved. in maintenance of cardiac catecholamine content: relative importance of synthesis and re-uptake. Brit. J. Pharmacol. 37, 24 - 33 (1969).

    CAS  Google Scholar 

  5. Brenner, G. M. and H. C. Stanton, Adrenergic mechanisms responsible for submandibular salivary glandulär hypertrophy in the rat. J. Pharmacol. exp. Ther. 173, 166 - 175 (1970).

    PubMed  CAS  Google Scholar 

  6. Brisse, B. und F. Bender, Lidocainwirkung auf Katecholamine und nicht veresterte Fettsäuren im Serum bei Herzinsuffizienz vor und nach körperlicher Belastung. Herz/Kreisl. 4, 25 - 27 (1972).

    Google Scholar 

  7. Caldarera, C. M., A. Casti, C. Rossoni, and O. Visioli, Polyamines and noradrenaline following myocardial hypertrophy. J. Mol. Cell. Cardiol. 3, 121 - 126 (1971).

    Article  PubMed  CAS  Google Scholar 

  8. Cession-Fossion, A., L’ouabaine diminue la teneur en noradrenaline du myocarde. C. R. Soc. Biol. 156, 1192-1193 (Paris 1962 ).

    CAS  Google Scholar 

  9. Chau, R., E. Friedman, B. Bhagat, and M. Krukowski, Reduction of endogenous norepinephrine and storage of H3-norepinephrine in myocardial necrosis induced by isoproterenol. Fed. Proc. 27, 413 (1968).

    Google Scholar 

  10. Chidsey, C. A. and E. Braunwald, Sympathetic activity and neurotransmitter depletion in congestive heart failure. Pharmacol. Rev. 18, 685 - 703 (1966).

    PubMed  CAS  Google Scholar 

  11. Chidsey, C. A., E. Braunwald, A. G. Morrow, and D. T. Mason, Myocardial norepinephrine concentration in man. (Effects of reserpine and congestive heart failure) New Engl. J. Med. 269, 653 - 658 (1963).

    CAS  Google Scholar 

  12. Chidsey. C. A., E. H. Sonnenblick, A. G. Morrow, and E. Mason, Norepinephrine stores and contractile force of papillary muscle from the failing human heart. Circulation 33, 43 - 51 (1966).

    PubMed  CAS  Google Scholar 

  13. Coleman, H. N., P. J. Dempsey, and T. Cooper, Myocardial oxygen consumption following chronic cardiac denervation. Amer. J. Physiol. 218, 475 - 478 (1970).

    PubMed  CAS  Google Scholar 

  14. Cooper, T., Surgical sympathectomy and adrenergic function. Pharmacol. Rev. 18, 611-618 (1966). 15. Costa, E., Simple neuronal models to estimate turnover rate of noradrenergic transmitter in vivo. Biochemistry of simple neuronal models. Adv. Bio- chem. Psychopharmacol. 2, 169 - 204 (1970).

    Google Scholar 

  15. Covell, J. W., C. A. Chidsey, and E. Braunwald, Reduction of the cardiac response to postganglionic sympathetic nerve Stimulation in experimental heart failure. Circulat. Res. 19, 51 - 56 (1966).

    Google Scholar 

  16. Dagett, W. M, V. L. Willman, T. Cooper, and C. R. Hanlon, Work capacity and efficiency of the autotransplanted heart. Circulation 35, 96 - 104 (1967).

    Google Scholar 

  17. Dempsey, P. J. and T. Cooper, Supersensitivity of the chronically denervated feline heart. Amer. J. Physiol. 215, 1245 - 1249 (1968).

    PubMed  CAS  Google Scholar 

  18. Dengler, H. J., I. A. Michaelson, H. E. Spiegel, and E. Titus, The uptake of labelled norepinephrine by isolated brain and other tissues of the cat. Int. J. Neuropharmacol. 1, 23 - 38 (1962).

    Article  CAS  Google Scholar 

  19. De Schryver, C., P. De Herdt, and J. Lammerant, Effect of physical training on cardiac catecholamines. Nature 214, 907 - 908 (1967).

    Article  PubMed  Google Scholar 

  20. De Schryver, J. Merfens- Strythagen, I. Becsey, and I. Lammerant, Effect of training on heart and skeletal muscle catecholamine concentration in rats. Amer. J. Physiol. 217, 1589 - 1592 (1969).

    Google Scholar 

  21. Dhalla, N. S., V. Balasubramanian, and J. Goldmann, Biochemical basis of heart function. III. Influence of isoproterenol on the norepinephrine stores in the rat heart. Canad. J. Physiol. Pharmacol. 49, 302 - 311 (1971).

    Article  CAS  Google Scholar 

  22. Donald, D. E., S. E. Milburn, and J. T. Shepherd, Effect of cardiac denervation on the maximal capacity for exercise in the racing greyhound. Amer. J. Physiol. 19, 849 - 852 (1964).

    CAS  Google Scholar 

  23. Donald, D. E. and S. L. Samueloff, Exercise tachycardia not due to blood-borne agents in canine cardiac denervation. Amer. J. Physiol. 211, 703 - 711 (1966).

    PubMed  CAS  Google Scholar 

  24. Donald, D. E. and J. T. Shepherd, Response to exercise in dogs with cardiac denervation. Amer. J. Physiol. 205, 393 - 400 (1963).

    PubMed  CAS  Google Scholar 

  25. Dorigotti, L., M. Gaetani, A. H. Glaser, and E. Turella, Competitive antagonism of isoproterenol-induced cardiac necrosis by ß-adrenoreceptor blocking agents. J. Pharm. Pharmacol. 21, 188 - 191 (1969).

    Article  PubMed  CAS  Google Scholar 

  26. Fischer, J. E., W. D. Horst, and I. J. Kopin, Norepinephrine metabolism in hypertrophied rat hearts. Nature 207, 951 - 953 (1965).

    Article  PubMed  CAS  Google Scholar 

  27. Fitzgerald, J. D., Perspectives in adrenergic ß-blockade. Clin. Pharmacol. Ther. 10, 292-306 (1969). 29. Fleckenstein, A., Specific inhibitors and Promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions. In: Calcium and the heart. Eds. P. Harris and L. H. Opie. 135 - 181 ( London/New York 1971 ).

    Google Scholar 

  28. Förster, W. and V. Rösler, Über die amindepletierende Wirkung verschiedener Digitaliskörper. Ein Beitrag zur Aufklärung des Wirkungsmechanismus der Herzglykoside. Experientia 23, 475-476 (Basel 1967 ).

    Google Scholar 

  29. Gaffney, T. E., C. A. Chidsey, and E. Braunwald, Study of the relationship between the neurotransmitter störe and adrenergic nerve block induced by reserpine and guanethidine. Circulat. Res. 12, 264 - 268 (1963).

    PubMed  CAS  Google Scholar 

  30. Gillis, R. A., B. Levitt, A. Raines, Y. J. Sohn, and F. G. Standaert, Effect of ouabain on sympathetic, vagus und phrenic nerve activity. Pharmacologist 11, 244 (1969).

    Google Scholar 

  31. Gold, H. K., K H. Prindle, G. S. Levey, and S. E. Epstein, Effects of experimental heart failure on the capacity of glucagon to augment myocardial centractility and activate adenyl cyclase. J. Clin. Invest. 49, 999 - 1006 (1970).

    Article  PubMed  CAS  Google Scholar 

  32. Goldstein, R. E., C. L. Skelton, G. S. Levey, D. L. Glancy, G. D. Beiser, and S. E. Epstein, Effects of chronic heart failure on the capacity of glucagon to enhance contractility and adenyl cyclase activity of human papillär muscle. Circulation 44, 638 - 648 (1971).

    PubMed  CAS  Google Scholar 

  33. Griepp, R. B., E. B. Stinson, E. Dong, D. A. Clark, and N.E. Shumway, Hemodynamic Performance of the transplanted human heart. Surgery 70, 88 - 96 (1971).

    PubMed  CAS  Google Scholar 

  34. Hayduk, K., H. M. Brecht, A. Vladutiu, S. Simard, J. M. Rojo- Ortega, L. Belleau, R. Boucher, and J. Genest, Renin activity and norepinephrine, cation, and water contents of cardiovascular tissue of dogs with congestive heart failure and ascites. Canad. D. Physiol. Pharmacol. 48, 463 - 468 (1970).

    Article  CAS  Google Scholar 

  35. Hecht, A., Einführung in experimentelle Grundlagen moderner Herzmuskel-Pathologie. (Jena 1970 ).

    Google Scholar 

  36. Holtz, P. and D. Palm, Brenzkatechinamine und andere sympatho- mimetische Amine, Biosynthese und Inaktivierung, Freisetzung und Wirkung. Ergebn. Physiol. 58, 1-580 (Berlin/Heidelberg/New York 1966 ).

    Google Scholar 

  37. Ito, Y., The tissue catecholamine concentration of the rabbit in experimental cardiac failure. Jap. Circulat. J. 32, 761 - 772 (1968).

    Article  CAS  Google Scholar 

  38. Jost, J.-P. and H. V. Rickenberg, Cyclic AMP. Ann. Rev. Biochem. 40, 741 - 774 (1971).

    Article  CAS  Google Scholar 

  39. Kako, K., The effect of a ß- adrenergic blocking agent on chemical changes in isoproterenol induced myocardial necrosis. Canad. J. Physiol. Pharmacol. 44, 678 - 682 (1966).

    Article  CAS  Google Scholar 

  40. Kahn, D. S., G. Rona, and C. I. Chappel, Cardiac pathology induced by isoproterenol and related amines. Ann. N. Y. Acad. Sei. 156, 285 - 293 (1969).

    Article  CAS  Google Scholar 

  41. Kirshner, N. and O. H. Viveros, Quantal aspects of the secretion of catecholamines and dopamine-ß- hydroxylase from the adrenal medulla. In: New Aspects of storage and release mechanisms of catecholamines. Bayer-Symposium II. eds. H. J. Schümann and G. Kroneberg 78 - 88 ( Berlin/Heidelberg/New York 1970 ).

    Google Scholar 

  42. Kizer, D. E. and B. A. Howell, Stimulation of DNA-synthesis and AMP deaminase activity in rat hearts during isoproterenol-induced myocardial infaretion. Chem.-Biol. Interactions 2, 235- 246 (1970).

    Article  Google Scholar 

  43. Koch-Weser, J., Beta-receptor blockade and myocardial effects of cardiac glycosides. Circulat. Res. 28, 109 - 118 (1971).

    PubMed  CAS  Google Scholar 

  44. Kones, R. J. and J. H. Philipps, Glucagon: present status in cardiovascular disease. Clin. Pharmacol. Ther. 12, 427 - 444 (1971).

    PubMed  CAS  Google Scholar 

  45. Kramer, R. S., D. T. Mason, and E. Braunwald, Augmented sympathetic neurotransmitter activity in the peripheral vascular bed of patients with congestive heart failure and cardiac norepinephrine depletion. Circulation 38, 629 - 634 (1968).

    PubMed  CAS  Google Scholar 

  46. Leachman, R. D., D. V. P. Cokkinos, R. Cabrera, L, L. Leatherman, and D. G. Rochelle, Response of the transplanted, denervated human heart to cardiovascular drugs. Amer. J. Cardiol. 27, 272 - 276 (1971).

    Article  PubMed  CAS  Google Scholar 

  47. Lee, K. S. and W. Klaus, The subcellular basis for the mechanism of inotropic action of cardiac glycosides. Pharmacol. Rev. 23, 193 - 261 (1971).

    PubMed  CAS  Google Scholar 

  48. Lee, W. C. and F. E. Shideman, Role of myocardial catecholamines in cardiac contractility. Science 129, 967 - 968 (1959).

    Article  PubMed  CAS  Google Scholar 

  49. Lee, W. C., C. S. Yoo, and S. H. Kang, The relationship between myocardial catecholamines and the heart rate. Arch. Int. Pharmacodyn. 152, 156 - 169 (1964).

    PubMed  CAS  Google Scholar 

  50. Levy, M. N., Sympathetic-parasympathetic interactions in the heart. Circulation Res. 29, 437 - 445 (1971).

    PubMed  CAS  Google Scholar 

  51. Lockett, M. F., Dangerous effects of isoprenaline in myocardial failure. Lancet 1965/II, 104-106.

    Google Scholar 

  52. Loubatieres, A., P. Bouyard, J. Chapal, M. Klein et A. M. Roudot, Effets de la g-strophanthine sur le taux des catecholamines cardiaques. C. R. Soc. Biol. 159, 948-950 (Paris 1965 ).

    CAS  Google Scholar 

  53. Martorana, P. A., The role of cyclic AMP in isoprenaline-induced cardiac necroses in the rat. J. Pharm. Pharmac. 23, 200 - 203 (1971).

    Article  CAS  Google Scholar 

  54. McLain, P. L., Effects of cardiac glycosides on spontaneous activity in vagus and sympathetic nerves of cats. Int. J. Neuropharmacol. 8, 379 - 387 (1969).

    Article  PubMed  CAS  Google Scholar 

  55. Mueller, R. A. and J. Axelrod, Abnormal cardiac norepinephrine storage in isoproterenol-treated rats. Circulat. Res. 23, 771 - 778 (1968).

    PubMed  CAS  Google Scholar 

  56. Mueller, R. A. and H. Thoenen, Cardiac catecholamine synthesis, turnover, and metabolism with isoproterenol-induced myocytolysis. Cardiovasc. Res. 5, 364 - 370 (1971).

    Article  PubMed  CAS  Google Scholar 

  57. Östman, I. and 7. O. Sjöstrand, Effect of prolonged physical training on the catecholamine levels of the heart and the adrenals of the rat. Acta physiol. Scand. 82, 202 - 208 (1971).

    Article  PubMed  Google Scholar 

  58. Palm, D., H. Grobecker, and I. J. Bäk, Membrane effects of catecholamine releasing drugs. In: New aspects of storage and release mechanisms of catecholamines. Bayer Symposium II. eds. H. J. Schümann and G. Kroneberg, 188 - 198 ( Berlin/Heidelberg/New York 1970 ).

    Google Scholar 

  59. Pool, P. F., J. W. Cowell, M. Levitt, J. Gibb, and E. Braunwald, Reduction of cardiac tyrosine hydroxylase activity in experimental congestive heart failure. Its role in the depletion of cardiac norepinephrine stores. Circulat. Res. 20, 349 - 353 (1967).

    PubMed  CAS  Google Scholar 

  60. Potter, L. T., T. Cooper, V. L. William, and D. E. Wolfe, Synthesis, binding, release, and metabolism of norepinephrine in normal and transplanted dog heearts, Circulat. Res. 16, 468 - 481 (1965).

    CAS  Google Scholar 

  61. Robison, G. A., R. W. Butcher, and E. W. Sutherland, Adenylcyclase as an adrenergic receptor. Ann. N. Y. Acad. Sci. 139, 703 - 723 (1967).

    Article  PubMed  CAS  Google Scholar 

  62. Robison, G. A., R. W. Butcher, and E. W. Sutherland, Cyclic AMP (New York/London 1971 ).

    Google Scholar 

  63. Sassa, H., Mechanism of myocardial catecholamine depletion in cardiac hypertrophy and failure in rabbits. Jap. Circulat. J. 35, 391 - 403 (1971).

    Article  CAS  Google Scholar 

  64. Schreiber, S. S„ I. L. Klein, M. Oratz, and M. A. Rothschild, Adenyl cyclase activity and cyclic AMP in acute cardiac overload: a method for measuring cyclic AMP production based on ATP specific activity. J. Mol. Cell. Cardiol. 2, 55 - 65 (1971).

    Article  PubMed  CAS  Google Scholar 

  65. Spann, J. F., R. A. Buccino, E. H. Sonnenblick, and E. Braunwald, Contractile State of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and heart failure. Circulat. Res. 21, 341 - 354 (1967).

    PubMed  Google Scholar 

  66. Spann, J. F., C. A. Chidsey, P. E. Pool, and E. Braunwald, Mechanism of norepinephrine depletion in experimental heart failure produced by aortic constriction in the guinea pig. Circulat. Res. 17, 312 - 321 (1965).

    PubMed  CAS  Google Scholar 

  67. Spann, J. F., E. H. Sonnenblick, T, C. oper, C. A. Chidsey, V. L. Willman, and E. Braunwald, Studies on digitalis XIV: Influence of cardiac norepinephrine stores on the response of isolated heart muscle to digitalis. Circulat. Res. 19, 326 - 331 (1966).

    PubMed  CAS  Google Scholar 

  68. Spann, J. F., E. H. Sonnenblick, T. Cooper, C. A. Chidsey, V. L. Willman, and E. Braunwald, Cardiac norepinephrine stores and the contractile State of heart muscle. Circulat. Res. 19, 317 - 325 (1966).

    PubMed  CAS  Google Scholar 

  69. Sun, S.-C., R. S. Sohal, H. L. Colcolough, and G. E. Burch, Histochemical and electronrnicroscopic studies of the effects of reserpine on the heart muscle of mice. J. Pharmacol. exp. Ther. 161, 210 - 221 (1968).

    PubMed  CAS  Google Scholar 

  70. Sutherland, E. W., G. A. Robison, and R. W. Butcher, Some aspects of the biological role of adenosine 3’ 5’-monophosphate (cyclic AMP). Circulat. Res. 37, 279 - 306 (1968).

    CAS  Google Scholar 

  71. Tanz, R. D., The action of ouabain on cardiac muscle treated with reserpine and dichlorisoproterenol. J. Pharmacol. exp. Ther. 144, 205 - 213 (1964).

    PubMed  CAS  Google Scholar 

  72. Tanz, R. D., W. M. Coram, C. Brining, and T. Cavaliere, The inotropic action of ouabain in relation to ventricular norepinephrine content. Arch. Int. Pharmacodyn. 173, 294 - 305 (1968).

    PubMed  CAS  Google Scholar 

  73. Tanz, R. D. and S. M. Marcus, Influence of endogenous cardiac catecholamine depletion on the force and rate of isolated heart preparations and their response to ouabain. J. Pharmacol. exp. Ther. 151, 38 - 45 (1966).

    PubMed  CAS  Google Scholar 

  74. Vogel, J, H. K., D. Jacobowitz, and C. A. Chidsey, Distribution of norepinephrine in the failing bovine heart. Correlation of chemical analysis and fluorescence microscopy. Circulat. Res. 24, 71 - 84 (1969).

    PubMed  CAS  Google Scholar 

  75. Wilcken, P. E. L., D. Brender, G. J. MacDonald, C. D. Shorley, and A. Hinierberger, Effect of reserpine on the strueture of heart mitochondria and the relation to catecholamine depletion. Circulat. Res. 20/21, Suppl. III, 203 - 210 (1967).

    Google Scholar 

  76. Wood, G. W., G. E. Lindenmayer, and A. Schwartz, Myocardial synthesis of ribonucleic acid. I. Stimulation of isoproterenol. J. Mol. Cell. Cardiol. 3, 127 - 138 (1971).

    Article  PubMed  CAS  Google Scholar 

  77. Yamazaki, N. and K. Ogawa, Cardiac catecholamine metabolism in heart failure. Jap. Circulat. J. 35, 965 - 971 (1971).

    Article  CAS  Google Scholar 

  78. Zaimis, E., Reserpine-induced circulatory failure. Nature 192 521-523 (London 1961 ).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmakologisches Institut der Universität, 6000, Frankfurt am Main, Theodor-Stern-Kai 7, Germany

    D. Palm

Authors
  1. D. Palm
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Bad Nauheim, Germany

    Rudolf Thauer  & Klaus Pleschka  & 

  2. Giessen, Germany

    Rudolf Thauer  & Klaus Pleschka  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1972 Dr. Dietrich Steinkopff Verlag, Darmstadt

About this paper

Cite this paper

Palm, D. (1972). Brenzkatechinamine und Myokardfunktion. In: Thauer, R., Pleschka, K. (eds) Herzhypertrophie. Verhandlungen der Deutschen Gesellschaft für Kreislaufforschung, vol 38. Steinkopff. https://doi.org/10.1007/978-3-642-72305-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72305-6_4

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-0361-8

  • Online ISBN: 978-3-642-72305-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation